F-group (family)
232.1.1.6 DDAH_eukar
Ligands and drugs
95
Member domains
43
with ligand contacts (≤ 4 Å)
45.3% of members
44
with DrugDomain annotations
46.3% of members
16
with a DrugBank compound
16.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 232.1.1.6 belongs to X-group 232 Pentein, which binds 9.0 ligand superclasses per 20 proteins, broader than 80% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00125 | ARG | Arginine | 4 |
| DB00129 | ORN | Ornithine | 3 |
| DB00155 | CIR | Citrulline | 3 |
| DB04422 | HCS | Homocysteine | 2 |
| DB00145 | GLY | Glycine | 1 |
| DB00213 | — | — | 1 |
| DB00736 | — | — | 1 |
| DB05351 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NO6 | S-[(pyridin-2-yl)methyl]-L-cysteine | 6 |
| ARG | ARGININE | 4 |
| ZNmetal | ZINC ION | 4 |
| CIR | CITRULLINE | 3 |
| ORN | L-ornithine | 3 |
| D20 | N~5~-{IMINO[(2-METHOXYETHYL)AMINO]METHYL}-L-ORNITHINE | 2 |
| HCS | 2-AMINO-4-MERCAPTO-BUTYRIC ACID | 2 |
| HM3 | (4-chloropyridin-2-yl)methanol | 2 |
| LN5 | N5-(1-iminopropyl)-L-ornithine | 2 |
| LN6 | N~5~-[(1E)-pentanimidoyl]-L-ornithine | 2 |
| LN7 | N~5~-[(1S)-1-aminopentyl]-L-ornithine | 2 |
| NOU | (2S)-2-amino-4-[(pyridin-2-yl)amino]butanoic acid | 2 |
| NQ6 | N-(pyridin-2-yl)-L-asparagine | 2 |
| SMZ | N~5~-[(E)-imino(methylsulfanyl)methyl]-L-ornithine | 2 |
| CL | CHLORIDE ION | 1 |
| GBG | N~6~-[(1E)-2-chloroethanimidoyl]-L-lysine | 1 |
| GLY | GLYCINE | 1 |
| M3B | (1~{S})-~{N}'-(4-azanylbutyl)-~{N}"-(2-methoxyethyl)methanetriamine | 1 |